scout
|Videos|November 1, 2017

Treatments on the Horizon in NETs

Matthew Kulke, MD, director, Neuroendocrine and Carcinoid Tumors Program, Dana-Farber Cancer Institute, discusses treatment options on the horizon in the treatment of neuroendocrine tumors (NETs) during the 2017 NANETS Symposium.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME